Literature DB >> 7122393

Reversible agranulocytosis in association with cimetidine and hepatic failure.

D S Lewis, E R Beck.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7122393      PMCID： PMC2426507          DOI： 10.1136/pgmj.58.681.443

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  6 in total

1.  Transient neutropenia in a patient receiving cimetidine.

Authors:  M H Ufberg; C M Brooks; P R Bosanac; J E Kintzel
Journal:  Gastroenterology       Date:  1977-09       Impact factor: 22.682

2.  Pharmacological evaluation of cimetidine, a new histamine H2-receptor antagonist, in healthy man.

Authors:  W L Burland; W A Duncan; T Hesselbo; J G Mills; P C Sharpe; S J Haggie; J H Wyllie
Journal:  Br J Clin Pharmacol       Date:  1975-12       Impact factor: 4.335

3.  Cimetidine and granulocytopenia.

Authors:  J W Freston
Journal:  Ann Intern Med       Date:  1979-02       Impact factor: 25.391

4.  [Plasma concentrations of cimetidine in cirrhotic and non-cirrhotic patients with upper digestive tract hemorrhage (author's transl)].

Authors:  T Dupont; M Beaugrand; J M Brunet; M Azouz-Abdallah; D Baylocq; G Champault; J P Ferrier
Journal:  Gastroenterol Clin Biol       Date:  1981-02

5.  Cimetidine and Agranulocytosis.

Authors:  S A Klotz; B F Kay
Journal:  Ann Intern Med       Date:  1978-04       Impact factor: 25.391

6.  Cimetidine clearance and bioavailability in hepatic cirrhosis.

Authors:  J Sonne; H E Poulsen; M Døssing; N E Larsen; P B Andreasen
Journal:  Clin Pharmacol Ther       Date:  1981-02       Impact factor: 6.875
  6 in total
  1 in total

Review 1.  Haematological adverse effects of histamine H2-receptor antagonists.

Authors:  J P Aymard; B Aymard; P Netter; B Bannwarth; P Trechot; F Streiff
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.